230 related articles for article (PubMed ID: 29187174)
1. Intra-tumor heterogeneity in breast cancer has limited impact on transcriptomic-based molecular profiling.
Karthik GM; Rantalainen M; Stålhammar G; Lövrot J; Ullah I; Alkodsi A; Ma R; Wedlund L; Lindberg J; Frisell J; Bergh J; Hartman J
BMC Cancer; 2017 Nov; 17(1):802. PubMed ID: 29187174
[TBL] [Abstract][Full Text] [Related]
2. De novo transcriptomic subtyping of colorectal cancer liver metastases in the context of tumor heterogeneity.
Moosavi SH; Eide PW; Eilertsen IA; Brunsell TH; Berg KCG; Røsok BI; Brudvik KW; Bjørnbeth BA; Guren MG; Nesbakken A; Lothe RA; Sveen A
Genome Med; 2021 Sep; 13(1):143. PubMed ID: 34470666
[TBL] [Abstract][Full Text] [Related]
3. An integration of complementary strategies for gene-expression analysis to reveal novel therapeutic opportunities for breast cancer.
Bild AH; Parker JS; Gustafson AM; Acharya CR; Hoadley KA; Anders C; Marcom PK; Carey LA; Potti A; Nevins JR; Perou CM
Breast Cancer Res; 2009; 11(4):R55. PubMed ID: 19638211
[TBL] [Abstract][Full Text] [Related]
4. Transcriptomic and proteomic intra-tumor heterogeneity of colorectal cancer varies depending on tumor location within the colorectum.
Árnadóttir SS; Mattesen TB; Vang S; Madsen MR; Madsen AH; Birkbak NJ; Bramsen JB; Andersen CL
PLoS One; 2020; 15(12):e0241148. PubMed ID: 33332369
[TBL] [Abstract][Full Text] [Related]
5. An Integrative Approach for Identifying Network Biomarkers of Breast Cancer Subtypes Using Genomic, Interactomic, and Transcriptomic Data.
Firoozbakht F; Rezaeian I; D'agnillo M; Porter L; Rueda L; Ngom A
J Comput Biol; 2017 Aug; 24(8):756-766. PubMed ID: 28650678
[TBL] [Abstract][Full Text] [Related]
6. Molecular subtyping for clinically defined breast cancer subgroups.
Zhao X; Rødland EA; Tibshirani R; Plevritis S
Breast Cancer Res; 2015 Feb; 17(1):29. PubMed ID: 25849221
[TBL] [Abstract][Full Text] [Related]
7. Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes.
Purrington KS; Visscher DW; Wang C; Yannoukakos D; Hamann U; Nevanlinna H; Cox A; Giles GG; Eckel-Passow JE; Lakis S; Kotoula V; Fountzilas G; Kabisch M; Rüdiger T; Heikkilä P; Blomqvist C; Cross SS; Southey MC; Olson JE; Gilbert J; Deming-Halverson S; Kosma VM; Clarke C; Scott R; Jones JL; Zheng W; Mannermaa A; ; Eccles DM; Vachon CM; Couch FJ
Breast Cancer Res Treat; 2016 May; 157(1):117-31. PubMed ID: 27083182
[TBL] [Abstract][Full Text] [Related]
8. Multiregional transcriptomics identifies congruent consensus subtypes with prognostic value beyond tumor heterogeneity of colorectal cancer.
Langerud J; Eilertsen IA; Moosavi SH; Klokkerud SMK; Reims HM; Backe IF; Hektoen M; Sjo OH; Jeanmougin M; Tejpar S; Nesbakken A; Lothe RA; Sveen A
Nat Commun; 2024 May; 15(1):4342. PubMed ID: 38773143
[TBL] [Abstract][Full Text] [Related]
9. Transcriptomic Profiling of Sequential Tumors from Breast Cancer Patients Provides a Global View of Metastatic Expression Changes Following Endocrine Therapy.
McBryan J; Fagan A; McCartan D; Bane FT; Varešlija D; Cocchiglia S; Byrne C; Bolger J; McIlroy M; Hudson L; Tibbitts P; Gaora PÓ; Hill AD; Young LS
Clin Cancer Res; 2015 Dec; 21(23):5371-9. PubMed ID: 26240272
[TBL] [Abstract][Full Text] [Related]
10. Multiplatform molecular profiling identifies potentially targetable biomarkers in malignant phyllodes tumors of the breast.
Gatalica Z; Vranic S; Ghazalpour A; Xiu J; Ocal IT; McGill J; Bender RP; Discianno E; Schlum A; Sanati S; Palazzo J; Reddy S; Pockaj B
Oncotarget; 2016 Jan; 7(2):1707-16. PubMed ID: 26625196
[TBL] [Abstract][Full Text] [Related]
11. Characterization of 1577 primary prostate cancers reveals novel biological and clinicopathologic insights into molecular subtypes.
Tomlins SA; Alshalalfa M; Davicioni E; Erho N; Yousefi K; Zhao S; Haddad Z; Den RB; Dicker AP; Trock BJ; DeMarzo AM; Ross AE; Schaeffer EM; Klein EA; Magi-Galluzzi C; Karnes RJ; Jenkins RB; Feng FY
Eur Urol; 2015 Oct; 68(4):555-67. PubMed ID: 25964175
[TBL] [Abstract][Full Text] [Related]
12. Microenvironmental Heterogeneity Parallels Breast Cancer Progression: A Histology-Genomic Integration Analysis.
Natrajan R; Sailem H; Mardakheh FK; Arias Garcia M; Tape CJ; Dowsett M; Bakal C; Yuan Y
PLoS Med; 2016 Feb; 13(2):e1001961. PubMed ID: 26881778
[TBL] [Abstract][Full Text] [Related]
13. Competing endogenous RNA network analysis identifies critical genes among the different breast cancer subtypes.
Chen J; Xu J; Li Y; Zhang J; Chen H; Lu J; Wang Z; Zhao X; Xu K; Li Y; Li X; Zhang Y
Oncotarget; 2017 Feb; 8(6):10171-10184. PubMed ID: 28052038
[TBL] [Abstract][Full Text] [Related]
14. Sequencing-based breast cancer diagnostics as an alternative to routine biomarkers.
Rantalainen M; Klevebring D; Lindberg J; Ivansson E; Rosin G; Kis L; Celebioglu F; Fredriksson I; Czene K; Frisell J; Hartman J; Bergh J; Grönberg H
Sci Rep; 2016 Nov; 6():38037. PubMed ID: 27901097
[TBL] [Abstract][Full Text] [Related]
15. Genome-driven integrated classification of breast cancer validated in over 7,500 samples.
Ali HR; Rueda OM; Chin SF; Curtis C; Dunning MJ; Aparicio SA; Caldas C
Genome Biol; 2014 Aug; 15(8):431. PubMed ID: 25164602
[TBL] [Abstract][Full Text] [Related]
16. Identification of Novel Breast Cancer Subtype-Specific Biomarkers by Integrating Genomics Analysis of DNA Copy Number Aberrations and miRNA-mRNA Dual Expression Profiling.
Li D; Xia H; Li ZY; Hua L; Li L
Biomed Res Int; 2015; 2015():746970. PubMed ID: 25961039
[TBL] [Abstract][Full Text] [Related]
17. Decoding transcriptomic intra-tumour heterogeneity to guide personalised medicine in ovarian cancer.
Tan TZ; Heong V; Ye J; Lim D; Low J; Choolani M; Scott C; Tan DSP; Huang RY
J Pathol; 2019 Mar; 247(3):305-319. PubMed ID: 30374975
[TBL] [Abstract][Full Text] [Related]
18. Breast cancer intra-tumor heterogeneity.
Martelotto LG; Ng CK; Piscuoglio S; Weigelt B; Reis-Filho JS
Breast Cancer Res; 2014 May; 16(3):210. PubMed ID: 25928070
[TBL] [Abstract][Full Text] [Related]
19. Determining breast cancer histological grade from RNA-sequencing data.
Wang M; Klevebring D; Lindberg J; Czene K; Grönberg H; Rantalainen M
Breast Cancer Res; 2016 May; 18(1):48. PubMed ID: 27165105
[TBL] [Abstract][Full Text] [Related]
20. Chromosome 22 array-CGH profiling of breast cancer delimited minimal common regions of genomic imbalances and revealed frequent intra-tumoral genetic heterogeneity.
Benetkiewicz M; Piotrowski A; Díaz De Ståhl T; Jankowski M; Bala D; Hoffman J; Srutek E; Laskowski R; Zegarski W; Dumanski JP
Int J Oncol; 2006 Oct; 29(4):935-45. PubMed ID: 16964389
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
